Skip to main content
FinSpry Logo
FinSpry
RMD logo
RMD
(NYSE)
ResMed Inc.
$207.78-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ResMed (RMD) Stock Price & Financial Analysis

ResMed Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$200.25 - $205.49
52-Week High$293.81
52-Week Low$198.61
Open$200.54
Volume1.03M
Average Volume (3M)1.29M
Market Cap29.42B
Shares Outstanding145.72M
P/E Ratio (TTM)19.36
Forward P/E17.03
Price to Sales (P/S)5.31
Price to Book (P/B)4.53
EV/EBITDA12.99
Revenue (TTM)5.54B
Net Income (TTM)1.52B
Free Cash Flow (TTM)1.75B
EPS (TTM)$10.36
Profit Margin27.44%
Operating Margin34.57%
Return on Equity (ROE)23.41%
Debt to Equity0.10
50-Day MA$225.88
200-Day MA$253.62
52-Week Change-19.74%
Annual Dividend$2.40
Dividend Yield1.18%
Payout Ratio23.17%
Last Dividend Ex-DateMay 14, 2026

Frequently Asked Questions About ResMed

What is the current stock price for RMD?

As of the latest trading session, RMD stock trades at $204.15. The 52-week range is $198.61–$293.81, with a day range of $200.25–$205.49.

What is the P/E ratio for RMD?

ResMed's trailing P/E ratio is 19.4, meaning investors pay $19.4 for every $1 of annual earnings. The forward P/E is 17.0, reflecting analyst expectations for future earnings. ResMed operates in the Healthcare sector.

Does RMD pay dividends?

Yes, ResMed pays a 1.18% annual dividend yield ($2.40 per share). The payout ratio is 23.2%. The last ex-dividend date was 2026-05-14.

What do analysts recommend for RMD?

Based on 3 analysts, the consensus for RMD is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of RMD?

ResMed's market capitalization is $29.75B, classifying it as a large-cap company. ResMed operates in the Healthcare sector within the Medical Instruments & Supplies industry.